NEW YORK (Reuters Health)—Rheumatoid arthritis (RA) is associated with more-severe acute coronary syndrome and poorer outcomes, according to a new study. “We found that despite the well-researched increased risk of acute coronary events (ACS) in RA, that there was almost no existing data describing clinical characteristics and outcomes of RA- and non-RA patients with ACS,”…
Cardiovascular Risk in Tocilizumab Therapy for RA
Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…
Depression May Increase Risk of Cardiovascular Disease for RA Patients
(Reuters Health)—Mental health problems, like anxiety and depression, may partly explain why people with rheumatoid arthritis have an increased risk of cardiovascular disease, according to a new study. Researchers linked anger, anxiety, depressive symptoms, job stress and low social support to increasing risk of hardening of the arteries, or atherosclerosis, for people with rheumatoid arthritis…
Atherosclerosis Insights May Shed Light on Lupus
New research compares pathogenic immune response in SLE with immune response that contributes to atherosclerotic plaque
Better Blood Pressure Screening Needed to Manage Cardiovascular Disease Risk in Rheumatoid Arthritis
Study finds hypertensive patients with RA less likely to be diagnosed with high blood pressure than non-RA patients
Diagnosis Trajectories Aid in Predicting Disease Progression
Gout important to progression of cardiovascular diseases in research analyzing ordered diagnoses of key conditions
Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium
Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered
Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?
Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region. (posted Jan. 14)
Researcher Studies Ways to Cut Cardiovascular Disease Risk in Rheumatoid Arthritis Patients
Better communication and more proactive partnerships between rheumatologists and primary care physicians may help modify CVD risk factors for patients with rheumatoid arthritis
Foundation Research Explores Relationship Between RA and Cardiovascular Disease
A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients